These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30131323)

  • 21. [Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma].
    Zheng W; Zhu J; Xie Y
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):875-6. PubMed ID: 19173838
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of transitioning inpatient chemotherapy regimens to the outpatient setting.
    Corsi MP; Shea K; W Knoebel R
    J Oncol Pharm Pract; 2020 Sep; 26(6):1324-1330. PubMed ID: 31822200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
    Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E
    Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical investigations in aggressive non-Hodgkin lymphoma.
    Jonathan F
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical and Cost Comparison Evaluation of Inpatient Versus Outpatient Administration of EPOCH-Containing Regimens in Non-Hodgkin Lymphoma.
    Evans SS; Gandhi AS; Clemmons AB; DeRemer DL
    J Pharm Pract; 2017 Aug; 30(4):400-405. PubMed ID: 27432462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study.
    Clin Adv Hematol Oncol; 2016 Feb; 14(2 Suppl 1):9-10. PubMed ID: 27007004
    [No Abstract]   [Full Text] [Related]  

  • 27. Obstructing endobronchial bands complicating radiation therapy for lung carcinoma.
    Miller KL; Harrell JH
    Chest; 1992 Jun; 101(6):1714-5. PubMed ID: 1376227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapsed diffuse large B-cell lymphoma--10 years later.
    Jain S; Shah N; Gregory S
    Clin Adv Hematol Oncol; 2011 Sep; 9(9):704-8. PubMed ID: 22402517
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma.
    Griffin PT; Ho VQ; Fulp W; Nishihori T; Shain KH; Alsina M; Baz RC
    Cancer; 2015 Oct; 121(20):3622-30. PubMed ID: 26149422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy.
    Matsukawa T; Suto K; Miyoshi H; Oshimi K; Ohshima K; Miyagishima T
    J Clin Exp Hematop; 2018 Dec; 58(4):184-187. PubMed ID: 30305476
    [No Abstract]   [Full Text] [Related]  

  • 31. Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.
    Borchmann P; Haverkamp H; Diehl V; Cerny T; Markova J; Ho AD; Eich HT; Mueller-Hermelink HK; Kanz L; Greil R; Rank A; Paulus U; Smardova L; Huber C; Dörken B; Nerl C; Krause SW; Mueller RP; Fuchs M; Engert A
    J Clin Oncol; 2011 Nov; 29(32):4234-42. PubMed ID: 21990399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
    Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
    Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous panniculitis-like T-cell lymphoma with extracutaneous dissemination demonstrated on FDG PET/CT.
    Babb A; Zerizer I; Naresh KN; Macdonald D
    Am J Hematol; 2011 Apr; 86(4):375-6. PubMed ID: 21442643
    [No Abstract]   [Full Text] [Related]  

  • 34. Destructive midline palatal lesion.
    Loudon JA; Marsh WL; Allen CM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Feb; 89(2):134-6. PubMed ID: 10673645
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary bone lymphoma involving bilateral tibia.
    Giardino AA; Shinagare AB; Shinagare SA; Dewar R; Weckstein D; Mauch P; Ramaiya NH; Freedman AS
    Am J Hematol; 2012 Sep; 87(9):924-5. PubMed ID: 22641233
    [No Abstract]   [Full Text] [Related]  

  • 36. [Malignant lymphoma and adult T-cell leukemia-lymphoma].
    Kato K
    Rinsho Ketsueki; 2014 Feb; 55(2):191-200. PubMed ID: 24598187
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatments for non-Hodgkin lymphoma in HIV-positive patients: quantifying incremental benefit from 1993 to 2004 by metaregression.
    Messori A; Fadda V; Maratea D; Trippoli S
    Am J Hematol; 2013 May; 88(5):435. PubMed ID: 23420571
    [No Abstract]   [Full Text] [Related]  

  • 38. [Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia].
    Sharkunov NN; Moiseyeva TN; Zybunova EE; Vinogradova OY; Kravchenko SK
    Ter Arkh; 2012; 84(11):71-4. PubMed ID: 23252253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-hodgkins lymphoma.
    Mead G; Woodcock J; Young C
    Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
    Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.